Pharma & Biotech Inside Biotech: Structure Therapeutics jolts oral GLP-1 race with mid-stage data By Proactive 17/03
Retail & consumer RBA hikes rates for second consecutive meeting as oil shock fears grip board By Proactive 17/03
Oil & Gas Saudi Petroline emerges as key workaround — but can’t fully offset Hormuz disruption By Proactive 17/03
Fashion & brands Week ahead: Investors face busy week as Fed and tech take center stage By Proactive 16/03
Software & services Tech Bytes: AI spending wave pushes Meta towards fresh round of tech layoffs By Proactive 16/03
Finance Dividends delivered more than half of FTSE 100 returns over the past decade By Proactive 14/03
Investments and investor services Frank Talk: Shipping stocks catch a windfall as freight markets go vertical By Proactive 13/03
Pharma & Biotech Inside Biotech: Phase III setback sends Immutep shares into freefall By Proactive 13/03
Basic Materials Ideal Power sets sights on data centers, EVs, and energy storage with B-TRAN By Proactive 12/03
Oil & Gas Traders put 72% odds on oil returning to $100 as Iran conflict hits new phase By Proactive 12/03
Software & services Tech Bytes: Atlassian cuts 1,600 jobs as AI continues to reshape tech workforce By Proactive 12/03
Pharma & Biotech Inside Biotech: FDA warning puts Novo Nordisk’s safety reporting under scrutiny By Proactive 11/03
Tech Tech Bytes: Australian researchers unveil photonic AI chip running at the speed of light By Proactive 10/03
Tech VivoPower leverages sovereign partnerships to secure AI infrastructure advantage By Proactive 09/03
Pharma & Biotech Inside Biotech: Nanosonics gains FDA clearance to expand CORIS endoscope coverage By Proactive 09/03
Tech Investors rotate beyond US tech as geopolitics and reporting-season volatility reshape portfolios By Proactive 09/03
